The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center
PrGF has a multifactorial pathogenesis, where DSA is not the only player, but its impact could vary depending on the transplant platform. Thus patient screening may be helpful to choose the best donor and transplant strategy.
Authors
- Sabrina Giammarco (ORCID: https://orcid.org/0000-0002-1382-5496)
- Filippo Frioni (ORCID: https://orcid.org/0000-0002-8427-2788)
- Maria Assunta Limongiello (ORCID: https://orcid.org/0000-0001-7802-8554)
- Patrizia Chiusolo (ORCID: https://orcid.org/0000-0002-1355-1587)
- A Manfreda
- Federica Sorà
- Elisabetta Metafuni
- Eugenio Galli (ORCID: https://orcid.org/0000-0002-2839-916X)
- Simona Sica (ORCID: https://orcid.org/0000-0003-2426-3465)
- E. Poggi (ORCID: https://orcid.org/0000-0002-0177-4097)
- Mariano Feccia
- Andrea Bacigalupo (ORCID: https://orcid.org/0000-0002-8169-7289)
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Agostino Gemelli University Polyclinic (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-08-21
- DOI
- https://doi.org/10.3389/fonc.2024.1387181
- Citations
- 1
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.45